PMCB

PharmaCyte BiotechD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Current thesis

Composite grade D from latest DB weights. Momentum 19.2 / Value 56.3

Posture

Defensive

Lead driver

Value

What changed

Next scheduled catalyst: earnings 2026-09-14.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.

Earnings

2026-09-14

Data freshness

Prices

Unavailable: Price unavailable

Fundamentals

As of 2026-08-17 • Vendor: Data Vendor v1

Scores

As of 2026-09-10 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net Neutral

Why

Momentum19 · Δ7d -

Value56 · Δ7d -0.0

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

• Next scheduled catalyst: earnings 2026-09-14.
• Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

• Mixed signals. Wait for cleaner trend confirmation.

Catalyst clock

2026-09-14

Lead driver: Value · See fundamentals

Momentum

25% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

75% active weight

Current posture

7d trendFlat

Δ7d

-0.0

Δ21d

-0.4

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 19.2 / Value 56.3

Fundamentals (TTM)

As of 2026-08-17

Market Cap

$5.82M

Beta

0.38

Shares Out

10.74M

P/E (TTM) · Derived

-0.2

P/S (TTM)

P/FCF (TTM) · Derived

-0.80

Rev YoY

-100.0%

EPS YoY

-128.4%

Gross Margin

-6142.0%

Op Margin

Net Debt

-$37.08M

Current Ratio

45.28

As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data